Coya Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$7,987,836 and profit margin reached -133%. Total operating expenses were $13,905,555.
Profit Margin
| 2020 | 0 | -733.19K | |
|---|---|---|---|
| 2021 | 0 | -4.87M | |
| 2022 | 0 | -14.67M | |
| 2023 | 6.00M | -7.98M | -133.08% |
COYA Income Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 6.00M | 0 | 0 | 0 |
Cost of revenue | 27.36K | 27.36K | 16.13K | 0 |
Gross profit | 5.97M | -27.36K | -16.13K | 0 |
Operating exp. | ||||
Research and development | 5.50M | 4.93M | 2.54M | 248.96K |
Selling and marketing | 0 | 0 | 0 | 445.13K |
Total operating expenses | 13.90M | 9.81M | 4.87M | 694.76K |
Operating income | -7.90M | -9.81M | -4.87M | -694.77K |
Other income (expenses), net | 639.36K | -2.43M | -21.48K | -38.42K |
Income before tax | -7.26M | -12.24M | -4.89M | -733.19K |
Income tax expense | 723.85K | 2.43M | -21.48K | -704 |
Net income | -7.98M | -14.67M | -4.87M | -733.19K |
Earnings per share | ||||
Basic EPS | -0.79 | -1.48 | -0.5 | -0.07 |
Diluted EPS | -0.79 | -1.48 | -0.5 | -0.07 |
| Data source | Data source |